玻璃体黄斑界面疾病临床资料及危险因素分析
本文选题:玻璃体黄斑界面疾病 切入点:住院患者 出处:《上海交通大学》2015年博士论文
【摘要】:背景:玻璃体黄斑界面(vitreomacular interface,VMI)疾病是一类由于VMI病理改变而引起的年龄相关性退行性病变,主要包括黄斑前膜(epiretinal membrane,ERM)、黄斑裂孔(macular hole,MH)、玻璃体黄斑牵引综合征(vitreomacular traction syndrome,VTS)、黄斑劈裂等。本课题组前期研究发现,VMI疾病已成为本院眼科手术量的第三位,是威胁老年人视觉质量的重要因素。控制VMI疾病的关键在于预防,而预防的关键在于明确其发病规律及其危险因素。然而,目前国内外尚缺乏这方面的研究报告。目的:分析近5年来本院眼科收治VMI疾病患者临床资料,初步筛选出与VMI疾病发生相关的危险因素。方法:(1)回顾性收集2010年1月至2014年12月本院眼科收治的VMI疾病患者临床资料,包括性别、年龄、主要诊断、其他诊断等,对以上资料进行统计分析,深入挖掘VMI疾病总体及各类病种患者特征;(2)回顾性收集2014年1月至2014年12月本院眼科收治入院的VMI疾病患者临床资料,并收集健康体检中心接受健康体检者临床资料作为对照组。对所有入选研究对象进行详细的眼科检查和病史收集,收集的病史资料包括:学历,抽烟、饮酒习惯,屈光状态,糖尿病、高血压及高脂血症等全身疾病史。并取血清进行性激素六项检测,包括:卵泡刺激素(FSH)、黄体生成激素(LH)、雌二醇(E2)、孕酮(P)、睾酮(T)及催乳素(PRL);(3)对以上计数资料采用卡方检验;对正态分布的计量资料采用独立样本t检验;对非正态分布的计量资料采用非参数检验进行组间比较,筛选出有统计学意义的变量,进行多因素非条件Logistic回归分析。结果:(1)近5年来,本院眼科收治入院的VMI疾病患者共979例,男性患者共287例,女性患者共692例,男女比例为1:2.4。近5年VMI疾病患者平均年龄61.6岁,其中男性患者62.3岁,女性患者61.4岁。男女性患者年龄分布情况不同:男性患者的发病率增高趋势较为缓和,总体呈现随年龄增长,发病率增高;而女性患者呈现绝经后发病率陡增的特点,集中分布于56~65岁年龄段。近5年主要诊断为特发性ERM、特发性MH及VTS的患者分别为454例、502例及24例,各病种历年患者量均呈现上升趋势;男女比例分别为1:2.3、1:2.4、1:3.8,男女性VMI疾病患者病谱构成情况类似。合并高血压、II型糖尿病的VMI疾病患者分别占11.5%、3.5%;(2)危险因素分析共纳入VMI疾病患者73例,男性患者20例,女性患者53例,平均年龄为63.4岁;男性患者中,IERM、IMH、VTS分别为9例、11例、1例;女性患者中,IERM、IMH、VTS分别为27例、23例、3例。单因素分析结果显示:男性VMI疾病患者以上各项研究因素与对照组差异均不显著;女性VMI疾病患者血清雌二醇(estrodiol,E2)、孕酮(progesterone,P)、催乳素(prolactin,PRL)及睾酮(testosterone,T)水平均显著低于对照组;对不同病种女性VMI疾病患者进一步进行分析,女性IERM及IMH患者分别在血清E2、T及E2、P、T水平上显著低于对照组。结论:近5年来,本院眼科VMI疾病收治量逐年稳步递增。绝经后早期女性最为高发,男性患者发病晚于女性,且发病率随年龄增高而上升。女性VMI疾病患者多项性激素水平显著低于对照组,E2与T尤为明显;未发现男性VMI疾病显著危险因素,提示男女性VMI疾病发病机制可能存在差异。
[Abstract]:Background: vitreous body interface (vitreomacular interface, VMI macular disease) is a kind of age-related degenerative lesions due to pathological changes caused by VMI, including macular epiretinal membrane (epiretinal, membrane, ERM), macular hole (macular hole, MH), vitreous body macular traction syndrome (vitreomacular traction, syndrome, VTS). Macular retinoschisis. Previous studies showed that VMI disease has become the hospital surgical volume of third, is an important factor threatening the visual quality of the elderly. The key control of VMI disease is prevention, and prevention is the key to clear the pathogenesis and risk factors. However, there is still lack of research report both at home and abroad. Objective: to analyze the past 5 years in our hospital were VMI disease patients with clinical data, preliminary screening risk factors associated with VMI disease. Methods: (1) were collected from January 2010 to The clinical data of patients with VMI disease from December 2014 in our hospital including gender, age, primary diagnosis, diagnosis, and statistical analysis of the above information, dig the overall VMI disease and all kinds of disease characteristics; (2) clinical data of patients with VMI disease were retrospectively collected from January 2014 to December 2014, the hospital admitted to hospital, and collect the health examination center received physical examination as the control group. The clinical data of detailed ophthalmologic examination and history collection of all subjects, history data collection including: education, smoking, drinking habits, refractive status, diabetes, hypertension and hyperlipidemia history of systemic diseases. And serum sex hormone six testing, including: follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and progesterone (P), testosterone (T) and prolactin (PRL); (3) the count data by chi square test ; independent samples t test was used for measurement data of normal distribution; the non normal distribution of the measurement data using non parametric test for comparison between groups, were statistically significant variables, multivariate non conditional Logistic regression analysis. Results: (1) in the past 5 years, the hospital admitted to hospital VMI disease patients with a total of 979 cases of male patients with a total of 287 cases of female patients in 692 cases, the ratio of male to female was nearly 5 years of 1:2.4. VMI disease patients with an average age of 61.6 years, of which 62.3 were male, female patients 61.4 years of age. Men and women of different age distribution of patients: the incidence of male patients were significantly increased in the trend of more moderate, generally with the increase of age, the increased incidence of female patients; and has the characteristics of incidence sharply after menopause, concentrated in the 56~65 years of age. The last 5 years for the diagnosis of idiopathic ERM, idiopathic MH and VTS patients were 454 cases, 502 cases and 24 Cases of various diseases over the years were increased; the proportion of men and women were 1:2.3,1:2.4,1:3.8, a similar spectrum of male and female VMI patients. Patients with hypertension, type II diabetes patients with VMI disease accounted for 11.5%, 3.5%; (2) risk factors included 73 patients with VMI disease, 20 cases of male patients. 53 cases of female patients, the average age is 63.4 years old; male patients, IERM, IMH, VTS were 9 cases, 11 cases, 1 cases; female patients, IERM, IMH, VTS were 27 cases, 23 cases, 3 cases. Univariate analysis showed that the factors of male VMI difference with control group. The studies above patients were not significant; female serum estradiol in patients with VMI disease (estrodiol, E2), progesterone (progesterone, P), prolactin (prolactin, PRL) and testosterone (testosterone, T) was significantly lower than the control group; the patients with different diseases of female VMI disease further analysis, female IERM And IMH patients respectively in serum E2, T and E2, P, T level was significantly lower than the control group. Conclusion: in the past 5 years, our hospital ophthalmology VMI disease steadily increasing. The high incidence of early postmenopausal women, the incidence of male patients than female, and the incidence rate increased with age and increased number. The sex hormone levels in female patients with VMI disease were significantly lower than the control group, E2 and T is obvious; no significant risk factors found in male VMI disease, suggesting that the male and female VMI disease mechanisms are different.
【学位授予单位】:上海交通大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R774.5
【相似文献】
相关期刊论文 前10条
1 陈锦礼;208例铸造工人黄斑状况的调查分析[J];职业医学;1993年04期
2 张伟,张尧贞;正常黄斑部阈值测定的初步报告[J];临床眼科杂志;1995年01期
3 吕沛霖,赵俊宏,赵燕麟,朱秀萍,李英泰;对黄斑分区标准化的建议[J];中华眼底病杂志;2004年02期
4 郭青;张岩;;高度近视眼黄斑劈裂光学相干断层扫描临床观察[J];解放军医学院学报;2013年04期
5 陈宗蕊;卵黄样黄斑部变性[J];北京医学;1981年05期
6 傅守静;;并发于视乳头小坑的黄斑部和傍视乳头的浆液性视网膜脱离[J];医学文摘(眼科学);1965年03期
7 林苍;;黄斑遗传变性1例报告[J];福建医药杂志;1985年03期
8 梁金宗;;强光源、高温环境工人黄斑部改变的初步调查[J];化工劳动保护(工业卫生与职业病分册);1992年05期
9 赵培泉;黄斑部视网膜下新生血管膜[J];国外医学.眼科学分册;1996年04期
10 亢晓丽,刘岩,郑彤,曹丽燕;孔源性视网膜脱离患者黄斑光敏感度的研究[J];中国医科大学学报;1998年06期
相关会议论文 前4条
1 陈丽红;;黄斑部出血的鉴别诊断[A];2008年浙江省眼科学术会议论文集[C];2008年
2 柏超然;;黄斑概论[A];浙江省中医药学会眼科分会中医眼科现代化学术交流会暨继续教育学习班资料[C];2005年
3 张新吉;;中心性浆液性脉络膜视网膜病变辩治体会[A];全国首届中青年中医眼科学术研讨会资料汇编[C];1996年
4 吴星伟;宫媛媛;汪辉;朱萍;邱庆华;宋义;谢正高;孙勇;;黄斑颗粒治疗年龄相关性黄斑变性的ERG研究[A];第六届全国中医中西医结合眼科学术交流会论文汇编[C];2007年
相关重要报纸文章 前4条
1 中国中医科学院眼科医院 谢立科 肖文峥 黄少兰;认识黄斑防病变[N];中国中医药报;2012年
2 宋爽;预防黄斑部退行性病变[N];保健时报;2003年
3 苏培增;视网膜病变可用复方丹参液[N];大众卫生报;2003年
4 周至安;任重道远[N];健康报;2005年
相关博士学位论文 前2条
1 郁肆青;玻璃体黄斑界面疾病临床资料及危险因素分析[D];上海交通大学;2015年
2 马群;超声乳化白内障吸除术后黄斑中央凹厚度检测及其临床价值的研究[D];华中科技大学;2009年
相关硕士学位论文 前10条
1 李伟;光学相干断层扫描在早期视网膜中央动脉阻塞上的诊断价值[D];石河子大学;2016年
2 丁银银;年龄相关性黄斑变性黄斑厚度与中医辨证分型相关性的探讨[D];南京中医药大学;2013年
3 王海欣;糖尿病视网膜病变患者黄斑厚度测量及对比研究[D];中国人民解放军军医进修学院;2006年
4 田芳;白内障超声乳化术后黄斑部的光学相干断层扫描[D];天津医科大学;2002年
5 李丽英;年龄相关性黄斑变性患者黄斑厚度的测量及对比研究[D];成都中医药大学;2008年
6 李在正;黄斑前膜术前黄斑微结构的变化对术后最佳矫正视力的影响[D];大连医科大学;2014年
7 邵岚;球后注射曲安奈德联合黄斑部格栅样光凝治疗糖尿病性黄斑水肿[D];新疆医科大学;2012年
8 彭晓丹;早期糖尿病视网膜病变黄斑区厚度分析[D];第二军医大学;2014年
9 党亚龙;i-MP对产生2型CNV的AMD患者最佳矫正视力及黄斑厚度的影响[D];郑州大学;2012年
10 薛林平;近视眼黄斑部不同区域视网膜光敏感度和固视稳定性的对比研究[D];湖北中医药大学;2013年
,本文编号:1687460
本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/1687460.html